The EU signed its first contract to deliver coronavirus vaccines

The European Commission (EC) has concluded the first agreement with the pharmaceutical company AstraZeneca on the purchase of 300 million doses of potential coronavirus vaccine. The relevant information was published on the website of the European Union’s supreme executive authority.

“Intensive European Commission negotiations continue to yield results. Today’s agreement is the first cornerstone of the European Commission’s vaccine strategy. This strategy will enable us to provide future vaccines to Europeans as well as our partners in other countries of the world,” said EC President Ursula von der Leyen.

After the vaccine proved to be safe and effective against COVID-19, the EC agreed on the purchase of 300 million doses of AstraZeneca vaccine with the possibility to purchase another 100 million on behalf of the EU member states. The Commission is currently continuing discussions with other vaccine manufacturers on similar agreements.

According to the EC, this agreement will be financed from the programme of emergency support instruments, which has funds to create a portfolio of potential vaccines with different profiles and produced by different companies.

“We will continue to work tirelessly to attract more candidates to the broad EU vaccine portfolio. A safe and effective vaccine remains the most reliable strategy to protect our citizens and the rest of the world from coronavirus,” added EU Commissioner for Health Stella Kyriakides.